Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

DM Ross, IS Pagani, N Shanmuganathan, CH Kok… - Leukemia, 2018 - nature.com
Following the achievement of deep molecular response on tyrosine kinase inhibitors (TKIs),
approximately half of patients with chronic myeloid leukemia (CML) can discontinue TKI and …
被引用次数：78 相关文章

[引用][C] Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

DM Ross, IS Pagani, N Shanmuganathan, CH Kok… - Leukemia, 2018 - cir.nii.ac.jp
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual
leukemic cells | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

D Ross, I Pagani, N Shanmuganathan, C Kok… - 2018 - hekyll.services.adelaide.edu.au
Following the achievement of deep molecular response on tyrosine kinase inhibitors (TKIs),
approximately half of patients with chronic myeloid leukemia (CML) can discontinue TKI and …

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells.

D Ross, I Pagani, N Shanmuganathan… - …, 2018 - researchnow.flinders.edu.au
Following the achievement of deep molecular response on tyrosine kinase inhibitors (TKIs),
approximately half of patients with chronic myeloid leukemia (CML) can discontinue TKI and …

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

DM Ross, IS Pagani, N Shanmuganathan, CH Kok… - Leukemia, 2018 - go.gale.com
Following the achievement of deep molecular response on tyrosine kinase inhibitors (TKIs),
approximately half of patients with chronic myeloid leukemia (CML) can discontinue TKI and …

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

D Ross, I Pagani, N Shanmuganathan, C Kok… - 2018 - digital.library.adelaide.edu.au
Following the achievement of deep molecular response on tyrosine kinase inhibitors (TKIs),
approximately half of patients with chronic myeloid leukemia (CML) can discontinue TKI and …

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells.

DM Ross, IS Pagani, N Shanmuganathan, CH Kok… - 2018 - ahro.austin.org.au
Following the achievement of deep molecular response on tyrosine kinase inhibitors (TKIs),
approximately half of patients with chronic myeloid leukemia (CML) can discontinue TKI and …

[引用][C] Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

DM Ross, IS Pagani, N Shanmuganathan… - …, 2018 - espace.library.uq.edu.au

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells.

DM Ross, IS Pagani, N Shanmuganathan, CH Kok… - Leukemia, 2018 - europepmc.org
Following the achievement of deep molecular response on tyrosine kinase inhibitors (TKIs),
approximately half of patients with chronic myeloid leukemia (CML) can discontinue TKI and …

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

DM Ross, IS Pagani, N Shanmuganathan… - …, 2018 - pubmed.ncbi.nlm.nih.gov
Following the achievement of deep molecular response on tyrosine kinase inhibitors (TKIs),
approximately half of patients with chronic myeloid leukemia (CML) can discontinue TKI and …